glp-1 clinical trials sign up drugs like Ozempic are proving effective in a variety of applications beyond managing diabetes and weight loss. On Real Talk MS, Dr. Ellen Mowry shares early findings from a trial GLP-1 and Addiction: Clinical Trials
Description
Yes, mild bruising occurs in 1015% of patients starting semaglutide and is not a sign of an allergic reaction or dangerous side effect
Shuoker B, Pichler MJ, Jin C, Sakanaka H, Wu H, Gascuea AM, et al
10.1021/acs.molpharmaceut.9b00308 [DOI] [PubMed] 67.Guan Y, et al
If prescribed, a licensed provider will include treatment instructions with your weight loss plan
So when you stop taking a GLP-1, food once again moves faster through the stomach, leading to weaker signals to stop eating and potentially increasing food intake
